Fibromyalgia
Conditions
Interventions
The present pilot study consisted of a non randomized, single arm, prepost intervention clinical trial, which was approved by the Ethics and Research Committee of the Universidad San Sebastián. 20 sub
F04.754.137.506.662
Sponsors
Universidad San Sebastián
Universidad San Sebastián
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Males and females; over 18 years of age; with a diagnosis of fibromyalgia issued by a medical professional under the ACR criteria (2016)
Exclusion criteria
Exclusion criteria: Subjects were excluded from the study when they presented pregnancy or lactation; oncologic pain; uncontrolled metabolic disorder; vertigo or similar condition or any cognitive impairment that hinders the understanding of the informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: After six weeks of treatment, a statistically significant decrease in pain intensity is expected compared to baseline;Expected outcome 2: After six weeks of treatment, a statistically significant increase in the pressure pain threshold of the upper trapezius, lumbar spine, and the knee is expected compared to baseline;Expected outcome 3: After six weeks of treatment, a statistically significant decrease in the risk of poor post-treatment outcomes is expected compared to baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 4: After one treatment session, a statistically significant increase in the pressure pain threshold of the upper trapezius, lumbar spine, and the knee is expected compared to baseline | — |
Countries
Chile
Contacts
Public ContactClaudio Carvajal-Parodi
Universidad San Sebastián
Outcome results
None listed